Key2Brain
PrivateLast Round
Grant
Apr 1, 2026
Total Funding Raised
$464,300
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Key2Brain operates in Healthcare & Life Sciences and is based in Solna. Its latest recorded funding round was a Grant round in April 2026.
Key2Brain is a biotechnology company that provides a platform technology for enhanced brain uptake of biologics and diagnostics for treating the central nervous system (CNS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Key2Brain Comparables
Compare Key2Brain with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate2Brain | 89% | |
| Ossianix | 86% | |
| Vect-Horus | 83% |
For institutional investors. Book with your work email.
Key2Brain Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2026 | ||||
| VC Round | Oct 2, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | May 18, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Key2Brain Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Uppsala Innovation Centre | Accelerator |
| Phase2Phase Biopharma | VC Round, Accelerator |
| Vinnova | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 221% MoM, reaching 1.2K.
- Apr 1, 2026
$3K raised from Vinnova
For institutional investors. Book with your work email.
Key2Brain Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Key2Brain's valuation, stock price, and market status.
Is Key2Brain a public or private company?
Key2Brain is a private company.
What is the current stock price of Key2Brain?
Key2Brain is a private company, so its shares have no public market price. Caplight tracks Key2Brain's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Key2Brain worth (valuation)?
Valuation information for Key2Brain is not publicly available.
Can I buy Key2Brain stock?
Key2Brain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Key2Brain's last funding round?
Key2Brain's most recent funding round was Grant on April 1, 2026.
Who are the main investors in Key2Brain?
Key investors in Key2Brain include Uppsala Innovation Centre, Phase2Phase Biopharma, Vinnova.
Will Key2Brain IPO soon?
No public IPO plans have been announced for Key2Brain.
How can I track Key2Brain secondary market activity?
Caplight tracks bids, offers, and trades in Key2Brain's shares on secondary markets.